OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Herbst on the International Lung Cancer Congress

August 9th 2011

Dr. Roy S. Herbst from Yale comprehensive cancer center on the International Lung Cancer Congress

Dr. Hoos Discusses the Next Steps for Ipilimumab

August 9th 2011

Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses the Next Steps for Ipilimumab

Dr. Herbst on the 2011 Lung Cancer Congress Topics

August 8th 2011

Dr. Roy Herbst from the Yale Comprehensive Cancer Center on Screening Studies at the Upcoming Lung Cancer Congress

Dr. West Talks About the Escalating Cost of Cancer Care

August 4th 2011

Dr. Jack West from the Swedish Cancer Institute Talks About the Escalating Cost of Cancer Care

Dr. Hoos Discusses Patients Eligible to Receive Ipilimumab

August 3rd 2011

Dr. Axel Hoos medical lead at Bristol-Myers Squibb Discusses Which Patients are Eligible to Receive Ipilimumab

Dr. Lichter on the Importance of the UN Summit on NCDs

August 2nd 2011

Dr. Allen S. Lichter the chief executive officer of ASCO on the Importance of the UN Summit on NCD

Dr. Kris on Patient Acceptance of Mutation Testing

August 2nd 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Patient Acceptance of Mutation Testing

Dr. West Discusses Anticipated Future Clinical Trials

August 1st 2011

Dr. Jack West from the Swedish Cancer Institute Talks About Anticipated Future Clinical Trials

Dr. Pruthi on What She Learned From the Flaxseed Trial

August 1st 2011

Dr. Sandhya Pruthi from the Mayo Clinic in Minnesota on What She Learned From the Flaxseed Trial

Dr. Hoos on the Ipilimumab Plus Dacarbazine Trial

July 29th 2011

Dr. Axel Hoos medical lead at bristol-myers squibb on the Ipilimumab Plus Dacarbazine Combination Trial

Dr. Lichter on ASCO's Global Cancer Care Initiatives

July 29th 2011

Dr. Allen S. Lichter the CEO of the American Society of Clinical Oncology (ASCO) on how they Address the World's Cancer Issues

Dr. Kris on How the Institutes in His Study Worked Together

July 28th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center on How the Institutes in the mutlicenter study examining driver mutations Worked Together

Dr. West on 4 Important Upcoming Clinical Trial Results

July 28th 2011

Dr. Jack West from Swedish Cancer Institute Discusses 4 Important Upcoming Clinical Trials Results in Lung Cancer.

Dr. Tsimberidou on the Next Steps for Personalized Care

July 27th 2011

Dr. Apostolia Tsimberidou from MD Anderson Cancer Center on the Next Steps for Personalized Care

Donna Berry Describes the ESRA-C Program

July 27th 2011

Donna Berry Describes the Electronic Self-Report Assessment for Cancer (ESRA-C) Program

Kristie Howlett on her Patient Hand Wiping Trial

July 26th 2011

Kristie Howlett from Sutter Roseville Medical Center on her Patient Hand Wiping Trial

Dr. Kris Discusses the Field of Mutation Testing

July 26th 2011

Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses the Field of Mutation Testing

Dr. Hoos on Why Melanoma is Amenable to Immunotherapy

July 26th 2011

Dr. Axel Hoos medical lead at Bristol-Myers Squibb on Why Melanoma is Amenable to Immunotherapy

Dr. Lichter Urges President Obama to Attend NCD Summit

July 25th 2011

Dr. Allen S. Lichter the CEO of ASCO Urges President Obama to Attend the UN Non-Communicable Diseases Conference

Reynaldo Garcia on CML BCR-ABL Testing

July 25th 2011

Reynaldo Garcia From Lineberger Comprehensive Cancer Center on CML BCR-ABL Testing Recommendation